An in vitro study with the U87 glioma cell line demonstrated that transfection of glioma cells with the miRNA miR-378 led to increased expression of SOX2, the stem cell surface marker CD133, and induction of stem cell properties. This evidence concerns the gene SOX2 and central nervous system cancer.